In recent years, many investigations have been conducted utilizing "neuropsychological" tests in an attempt to differentiate brain damage from schizophrenia. Neuropsychological tests are those primarily designed and/or utilized to provide information about the organic integrity of the human brain. The Trail Making Test, first used in this context by Armitage (1946) , has received much attention in this regard (Reitan, 1958 (Reitan, , 1959 . The results of these studies have confirmed the Trail Making Test's effectiveness in separating groups of brain-damaged from nonbrain-damaged subjects. However, reports of this test's ability to differentiate brain-damaged from psychotic subjects have not been as consistently encouraging (Brown, Casey, Fisch, & Neuringer, 1958; Orgel & McDonald, 1967; Watson, Thomas, Felling & Anderson, 1969) .
Studies designed to compare schizophrenia with brain damage have tended to treat brain damage as a unitary disorder (Watson et al., 1969) or with normative data derived from patients with mixed types of brain damage (Small, Small, Milstein, & Moore, 1965) . However, the scientific literature abounds with evidence that type of cerebral lesion and location of damage results in neuropsychologically identifiable behavioral deficits (Reitan, 1964; Yates, 1966) . In fact, differences in effects on the Trail Making Test have been shown between cerebral diseases which require medical treatment due to their acute and/or progressive nature as compared with conditions of cerebral damage of a longstanding, nonprogressive nature (Fitzhugh, Fitzhugh, & Reitan, 1963) . Klonoff, Fibiger, and Button (1970) itself has by no means been ruled in or out as a category of cerebral impairment.
In the current investigation, it was possible to examine nonpsychotic patients from a neurology service about whom well-documented information was available regarding location and type of lesion (cerebrovascular disease, neoplastic disease, and trauma). The purpose of this study was to compare the Trail Making Test performance of persons diagnosed as schizophrenic (a condition of unknown cerebral consequences) with persons in whom the damage to the brain was well-documented and of known type.
METHOD Subjects
Twenty patients diagnosed as schizophrenic with no evidence of past or present neurological damage or disease, electroconvulsive shock therapy, drug abuse, or alcoholism were selected. Each subject was an inpatient in an acute, intensive care, psychiatric hospital. One hundred and twenty patients with proven cerebral lesions made up the brain-damaged group. Three subgroups representing cerebrovascular disease, neoplastic disease, or trauma were composed of 40 subjects each. Table 1 presents the mean age, education, and Verbal, Performance, and Full Scale IQ of each of the four groups. The schizophrenic and traumatic injury groups were younger than the cerebrovascular and neoplastic disease group (F -4.T?, df = 3/136, /><.01). However, such an age difference reflects the expected age distribution of patients with the types of disorders represented in this study. Any attempts to force age equality upon groups with different types of cerebral disorders might render them nonrepresentative of the total population of persons with the types of disorders involved. Boll and Reitan (1973) f,ou,nd that performance on the Trail Making Test, Parts A and B, is not significantly correlated with age in patients aged 15-6S. This same study indicated that the effectiveness of this test to discriminate braindamaged from non-brain-damaged subjects was constant across this age range. No significant differences were found between the groups in amount of education. Psychometric intelligence is a variable dependent upon integrity of brain functions as well as environmental factors and therefore was neither experimentally nor statistically manipulated.
Procedure
Parts A and B of the Trail Making Test were individually administered to each patient by a trained technician who was unaware of the patient's diagnosis or the design of the study. Part A requires the subject to draw a line connecting 25 numbered circles placed randomly on a page. Part B requires the subject to draw a line connecting numbers and letters alternately, that is, 1, A, 2, B, 3, C, etc. The score for each part is the number of seconds required to complete the task. Each patient was tested in an entirely standardized manner. Table 2 presents the mean scores for each group of subjects on Parts A and B of the Trail Making Test. Grouping subjects according to the type of impairment (tumor versus cerebrovascular disease versus schizophenia versus trauma) resulted in significant differences in Trail Making performance between the groups (P = 6.18, dj = 3/136, /><.01). A significant Part A versus Part B difference (F = 136.89, df = 1/136, p < .001) was also apparent. The latter finding was entirely expected due to the increased difficulty on Part B as compared with Part A but does not represent an experimentally meaningful aspect of this investigation. Individual comparisons between the four impairment-type groups using Duncan's new multiple-range test (Edwards, 1960) indicated that on Trail Making Test, Part A, the schizophrenic group performed significantly better than the tumor group (p < .01) and cerebrovascular group (p < .05) but not significantly better than the trauma group. Results on the Trail Making Test, Part B, indicated significant differences between the schizophrenic group and each of the other three impairmenttype groups, with the schizophrenic group performing significantly better in each instance (p < .01).
RESULTS
Schizophrenia can be considered to be static or nonprogressive (not requiring medico-neurological treatment) with respect to impairment of adaptive abilities (Klonoff et al, 1970; Smith, 1964) . The traumatic head-injury subjects represented a second group whose current medical health was not in jeopardy despite the presence of documented brain damage. Cerebrovascular disease and neoplastic disease, on the other hand, represent two types of brain disease that have serious implications with respect to their need for current and/or ongoing medical attention in addition to their influence on the patient's future physical as well as mental ability to function adaptively. When an evaluation of a patient is performed, it would be of far greater value to 115.81 122.14 utilize the data to learn something about the patient's potential for future medical and psychological functioning than merely to attempt to label a patient as brain-damaged or non-braindamaged. The ability to differentiate between conditions which do or do not require active medico-neurological treatment will be most useful, whereas making a distinction between several static, possibly overlapping conditions not requiring medico-neurological treatment would be of lesser clinical significance. For this reason, the groups were divided into two groups for further analysis of comparison. Group 1 (no medical danger) was composed of all schizophrenic and traumatic brain-injury patients. Group 2 (neurologically ill) was composed of all cerebrovascular and neoplastic disease patients. There was a significant difference between these two groups (F = 10.72, dj = 1/138, p < .01). Duncan's new multiple-range test revealed that on the Trail Making Test, Part A and Part B, the no medical danger group performed significantly better than did the neurologically ill group (p < .01).
DISCUSSION
Comparison of the performance of schizophrenic patients versus patients with known types of cerebral damage indicates that schizophrenics perform significantly better on the Trail Making Test than do patients with brain tumors or cerebrovascular disease. Part B was performed more poorly by patients in all three groups of identified cerebral damage than by schizophrenics, while performance on Part A differentiated only the vascular and neoplastic disease groups from the schizophrenic group.
The significance of these findings is best indicated when patients with cerebral disease were compared with patients who were not currently suffering from a neurological disease requiring medico-neurological treatment. The latter group (schizophrenics and traumatic injury patients) was clearly less impaired on both Parts A and B of the Trail Making Test than was the neurologically ill group.
These results represent a very limited sample of behavior taken from subjects in each group. It is clear that a more extensive behavioral evaluation would have the expectancy of providing additional clinically useful information. However, when questions are phrased in a medico-neurologically meaningful manner, the neuropsychological examination may be of specific clinical value in dealing with the behavioral diversity presented by patients in psychiatric as well as neurologic hospital settings.
